These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 23741487

  • 1. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell.
    Yang Y, Li H, Hou S, Hu B, Liu J, Wang J.
    PLoS One; 2013; 8(5):e65309. PubMed ID: 23741487
    [Abstract] [Full Text] [Related]

  • 2. Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β-catenin signaling pathway.
    Fu X, Li H, Liu C, Hu B, Li T, Wang Y.
    Onco Targets Ther; 2016; 9():3815-27. PubMed ID: 27445486
    [Abstract] [Full Text] [Related]

  • 3. LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network.
    Liu TT, Li R, Liu X, Zhou XJ, Huo C, Li JP, Qu YQ.
    Int J Med Sci; 2021; 18(2):419-431. PubMed ID: 33390811
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling.
    Monroe JD, Moolani SA, Irihamye EN, Lett KE, Hebert MD, Gibert Y, Smith ME.
    Sci Rep; 2021 May 17; 11(1):10408. PubMed ID: 34001990
    [Abstract] [Full Text] [Related]

  • 5. Microarray data re-annotation reveals specific lncRNAs and their potential functions in non-small cell lung cancer subtypes.
    Zhou D, Xie M, He B, Gao Y, Yu Q, He B, Chen Q.
    Mol Med Rep; 2017 Oct 17; 16(4):5129-5136. PubMed ID: 28849055
    [Abstract] [Full Text] [Related]

  • 6. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y, Dong ZY, Wang JY.
    Eur Rev Med Pharmacol Sci; 2018 Aug 17; 22(15):4879-4887. PubMed ID: 30070323
    [Abstract] [Full Text] [Related]

  • 7. Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway.
    Ma LY, Xie XW, Ma L, Pang JL, Xiong XM, Zheng HD, Shen XL, Wen ZG, Wang HY.
    Eur Rev Med Pharmacol Sci; 2017 Jun 17; 21(11):2626-2634. PubMed ID: 28678322
    [Abstract] [Full Text] [Related]

  • 8. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
    Xu L, Xu Y, Yang M, Li J, Xu F, Chen BL.
    BMC Pulm Med; 2020 Oct 15; 20(1):266. PubMed ID: 33059643
    [Abstract] [Full Text] [Related]

  • 9. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P, Xu H, Xu C, Chen A, Chen L, Zhou M, Haq IU, Wu X, Mariyam Z, Feng Q.
    Chem Biol Interact; 2018 Dec 25; 296():154-161. PubMed ID: 30291867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB, Wang SX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 25; 23(3):1093-1101. PubMed ID: 30779077
    [Abstract] [Full Text] [Related]

  • 14. Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.
    Hu L, Chen J, Zhang F, Wang J, Pan J, Chen J, Wang Y.
    Biomed Res Int; 2017 Feb 25; 2017():7498151. PubMed ID: 29279851
    [Abstract] [Full Text] [Related]

  • 15. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
    Wang L, Shang X, Feng Q.
    Cancer Biol Ther; 2019 Feb 25; 20(3):261-271. PubMed ID: 30481109
    [Abstract] [Full Text] [Related]

  • 16. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
    Gao W, Liu Y, Qin R, Liu D, Feng Q.
    Biochem Biophys Res Commun; 2016 Jul 15; 476(1):35-41. PubMed ID: 27207836
    [Abstract] [Full Text] [Related]

  • 17. Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancer.
    Cheng N, Li X, Zhao C, Ren S, Chen X, Cai W, Zhao M, Zhang Y, Li J, Wang Q, Zhou C.
    Oncol Rep; 2015 Feb 15; 33(2):833-9. PubMed ID: 25482516
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy.
    Sun W, Zu Y, Fu X, Deng Y.
    Oncol Rep; 2017 Dec 15; 38(6):3347-3354. PubMed ID: 29130102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis.
    Sun J, Pan LM, Chen LB, Wang Y.
    Cell Cycle; 2017 Dec 15; 16(21):2100-2107. PubMed ID: 28961027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.